Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana
Rev. Soc. Bras. Med. Trop
;
54: e0305-2020, 2021. graf
Artigo
em Inglês
| LILACS
| ID: biblio-1155563
ABSTRACT
Abstract Cutaneous leishmaniasis (CL) involves several differential diagnoses as it lacks a gold standard diagnostic test. Its diagnosis is easier in endemic regions; however, many cases come from travelers to endemic areas. A 22-year-old patient, who had recently visited Oaxaca, Mexico, developed two asymptomatic ulcers weeks later on the left auricle and the nose. Leishmania mexicana was identified using polymerase chain reaction. The patient was treated with imiquimod 5% cream three times/week, providing favorable results after 12 weeks, without relapse 2 months after therapy. To our knowledge, this is the first case of CL due to L. mexicana effectively treated with imiquimod.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Leishmania mexicana
/
Leishmaniose Mucocutânea
/
Leishmaniose Cutânea
Tipo de estudo:
Estudo prognóstico
Limite:
Humanos
País/Região como assunto:
México
Idioma:
Inglês
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
Medicina Tropical
Ano de publicação:
2021
Tipo de documento:
Artigo
País de afiliação:
México
Instituição/País de afiliação:
Hospital General de México/MX
/
Instituto Nacional de Medicina Genómica/MX
/
Universidad Nacional Autónoma de México/MX
Similares
MEDLINE
...
LILACS
LIS